Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.

MLA

Oh, Mi-Kyung, et al. “Prohaptoglobin Inhibits the Transforming Growth Factor-β-Induced Epithelial-to-Mesenchymal Transition in Vitro by Increasing Smad1/5 Activation and Suppressing the Smad2/3 Signaling Pathway in SK-Hep1 Liver Cancer Cells.” PloS One, vol. 17, no. 5, May 2022, p. e0266409. EBSCOhost, https://doi.org/10.1371/journal.pone.0266409.

APA

Oh, M.-K., Joo, H., & Kim, I.-S. (2022). Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells. PloS One, 17(5), e0266409. https://doi.org/10.1371/journal.pone.0266409

Chicago

Oh, Mi-Kyung, Hansol Joo, and In-Sook Kim. 2022. “Prohaptoglobin Inhibits the Transforming Growth Factor-β-Induced Epithelial-to-Mesenchymal Transition in Vitro by Increasing Smad1/5 Activation and Suppressing the Smad2/3 Signaling Pathway in SK-Hep1 Liver Cancer Cells.” PloS One 17 (5): e0266409. doi:10.1371/journal.pone.0266409.